Organogenesis Holdings Narrows FY2026 Sales Guidance from $179.000M-$215.000M to $179.400M-$200.000M vs $196.050M Est
Benzinga Newsdesk 1 hour ago
NewsGuidance
Organogenesis Holdings (NASDAQ:ORGO) narrows FY2026 sales outlook from $179.000 million-$215.000 million to $179.400 million-$200.000 million vs $196.050 million estimate.
Organogenesis Holdings (NASDAQ:ORGO) narrows FY2026 sales outlook from $179.000 million-$215.000 million to $179.400 million-$200.000 million vs $196.050 million estimate.